Volpara Health Technologies Limited
VPAHF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $183 | $222 | $325 | $157 |
| - Cash | $12 | $17 | $30 | $31 |
| + Debt | $2 | $2 | $5 | $4 |
| Enterprise Value | $173 | $207 | $301 | $130 |
| Revenue | $33 | $24 | $18 | $12 |
| % Growth | 35% | 33.9% | 47.1% | – |
| Gross Profit | $30 | $22 | $17 | $11 |
| % Margin | 92.5% | 91.2% | 91.4% | 86% |
| EBITDA | -$7 | -$14 | -$17 | -$19 |
| % Margin | -20.8% | -57.1% | -92% | -158.2% |
| Net Income | -$9 | -$15 | -$16 | -$20 |
| % Margin | -28% | -63% | -88.6% | -160.9% |
| EPS Diluted | -0.036 | -0.061 | -0.065 | -0.094 |
| % Growth | 40.1% | 6.3% | 31.2% | – |
| Operating Cash Flow | -$4 | -$11 | -$13 | -$15 |
| Capital Expenditures | -$2 | -$2 | -$1 | -$1 |
| Free Cash Flow | -$6 | -$13 | -$14 | -$16 |